Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.

The phenotypic manifestations of mitochondrial DNA (mtDNA) mutations are modulated by mitochondrial DNA haplotypes, nuclear modifier genes and environmental factors. The yeast mitochondrial 15S rRNA C1477G (P(R) or P(R) 454) mutation corresponds to the human 12S rRNA C1494T and A1555G mutations, whi...

Full description

Bibliographic Details
Main Authors: Xiangyu He, Xiaoyu Zhu, Xuexiang Wang, Wei Wang, Yu Dai, Qingfeng Yan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3858254?pdf=render
_version_ 1811270467887038464
author Xiangyu He
Xiaoyu Zhu
Xuexiang Wang
Wei Wang
Yu Dai
Qingfeng Yan
author_facet Xiangyu He
Xiaoyu Zhu
Xuexiang Wang
Wei Wang
Yu Dai
Qingfeng Yan
author_sort Xiangyu He
collection DOAJ
description The phenotypic manifestations of mitochondrial DNA (mtDNA) mutations are modulated by mitochondrial DNA haplotypes, nuclear modifier genes and environmental factors. The yeast mitochondrial 15S rRNA C1477G (P(R) or P(R) 454) mutation corresponds to the human 12S rRNA C1494T and A1555G mutations, which are well known as primary factors for aminoglycoside-induced nonsyndromic deafness. Here we report that the deletion of the nuclear modifier gene MTO2 suppressed the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae. First, the strain with a single mtDNA C1477G mutation exhibited hypersensitivity to neomycin. Functional assays indicated that the steady-state transcription level of mitochondrial DNA, the mitochondrial respiratory rate, and the membrane potential decreased significantly after neomycin treatment. The impaired mitochondria could not produce sufficient energy to maintain cell viability. Second, when the mto2 null and the mitochondrial C1477G mutations co-existed (mto2(P(R))), the oxygen consumption rate in the double mutant decreased markedly compared to that of the control strains (MTO2(P(S)), mto2(P(S)) and MTO2(P(R))). The expression levels of the key glycolytic genes HXK2, PFK1 and PYK1 in the mto2(P(R)) strain were stimulated by neomycin and up-regulated by 89%, 112% and 55%, respectively. The enhanced glycolysis compensated for the respiratory energy deficits, and could be inhibited by the glycolytic enzyme inhibitor. Our findings in yeast will provide a new insight into the pathogenesis of human deafness.
first_indexed 2024-04-12T22:01:17Z
format Article
id doaj.art-006a8c342e6b4a1eba726c01d2aa98c1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T22:01:17Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-006a8c342e6b4a1eba726c01d2aa98c12022-12-22T03:15:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8149010.1371/journal.pone.0081490Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.Xiangyu HeXiaoyu ZhuXuexiang WangWei WangYu DaiQingfeng YanThe phenotypic manifestations of mitochondrial DNA (mtDNA) mutations are modulated by mitochondrial DNA haplotypes, nuclear modifier genes and environmental factors. The yeast mitochondrial 15S rRNA C1477G (P(R) or P(R) 454) mutation corresponds to the human 12S rRNA C1494T and A1555G mutations, which are well known as primary factors for aminoglycoside-induced nonsyndromic deafness. Here we report that the deletion of the nuclear modifier gene MTO2 suppressed the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae. First, the strain with a single mtDNA C1477G mutation exhibited hypersensitivity to neomycin. Functional assays indicated that the steady-state transcription level of mitochondrial DNA, the mitochondrial respiratory rate, and the membrane potential decreased significantly after neomycin treatment. The impaired mitochondria could not produce sufficient energy to maintain cell viability. Second, when the mto2 null and the mitochondrial C1477G mutations co-existed (mto2(P(R))), the oxygen consumption rate in the double mutant decreased markedly compared to that of the control strains (MTO2(P(S)), mto2(P(S)) and MTO2(P(R))). The expression levels of the key glycolytic genes HXK2, PFK1 and PYK1 in the mto2(P(R)) strain were stimulated by neomycin and up-regulated by 89%, 112% and 55%, respectively. The enhanced glycolysis compensated for the respiratory energy deficits, and could be inhibited by the glycolytic enzyme inhibitor. Our findings in yeast will provide a new insight into the pathogenesis of human deafness.http://europepmc.org/articles/PMC3858254?pdf=render
spellingShingle Xiangyu He
Xiaoyu Zhu
Xuexiang Wang
Wei Wang
Yu Dai
Qingfeng Yan
Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
PLoS ONE
title Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
title_full Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
title_fullStr Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
title_full_unstemmed Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
title_short Nuclear modifier MTO2 modulates the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae.
title_sort nuclear modifier mto2 modulates the aminoglycoside sensitivity of mitochondrial 15s rrna c1477g mutation in saccharomyces cerevisiae
url http://europepmc.org/articles/PMC3858254?pdf=render
work_keys_str_mv AT xiangyuhe nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae
AT xiaoyuzhu nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae
AT xuexiangwang nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae
AT weiwang nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae
AT yudai nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae
AT qingfengyan nuclearmodifiermto2modulatestheaminoglycosidesensitivityofmitochondrial15srrnac1477gmutationinsaccharomycescerevisiae